| Cardiovascular Risk Management |
1 |
1 |
| Lipids Management |
0 |
0.97 |
| Statins |
0 |
0.98 |
| Obesity |
0 |
0.42 |
| Type 2 Diabetes Mellitus |
0 |
0.24 |
| Body Mass Index |
0 |
0.2 |
| Cardiometabolic Risk Factors |
0 |
0.17 |
| GLP-1 Receptor Agonist |
0 |
0.99 |
| Cancer |
0 |
0.15 |
| Cardiovascular disease |
0 |
0.15 |
| Weight Loss |
0 |
0.15 |
| Pancreatic Cancer |
0 |
0.14 |
| Weight Management |
0 |
0.14 |
| Hepatocellular Carcinoma |
0 |
0.13 |
| Social Determinants of Health |
0 |
0.13 |
| NHS |
0 |
0.12 |
| Europe |
0 |
0.1 |
| Health Care Economics |
0 |
0.1 |
| Infarction |
0 |
0.1 |
| Myocardial Infarction (MI) |
0 |
0.1 |
| Quality of Life |
0 |
0.1 |
| Receptors |
0 |
0.1 |
| LDL Cholesterol |
0 |
0.07 |
| Liver Disease |
0 |
0.07 |